SEMA6C
gene geneOn this page
Also known as KIAA1869Sema-Y
Summary
SEMA6C (semaphorin 6C, HGNC:10740) is a protein-coding gene on chromosome 1q21.3, encoding Semaphorin-6C (Q9H3T2). Shows growth cone collapsing activity on dorsal root ganglion (DRG) neurons in vitro.
This gene encodes a member of the semaphorin family. Semaphorins represent important molecular signals controlling multiple aspects of the cellular response that follows CNS injury, and thus may play an important role in neural regeneration.
Source: NCBI Gene 10500 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 34 total
- MANE Select transcript:
NM_030913
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10740 |
| Approved symbol | SEMA6C |
| Name | semaphorin 6C |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1869, Sema-Y |
| Ensembl gene | ENSG00000143434 |
| Ensembl biotype | protein_coding |
| OMIM | 609294 |
| Entrez | 10500 |
Gene structure
Transcript identifiers
Ensembl transcripts: 36 — 32 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000341697, ENST00000368912, ENST00000368913, ENST00000368914, ENST00000464018, ENST00000479820, ENST00000485745, ENST00000489944, ENST00000866869, ENST00000866870, ENST00000866871, ENST00000866872, ENST00000866873, ENST00000866874, ENST00000866875, ENST00000866876, ENST00000866877, ENST00000866878, ENST00000866879, ENST00000866880, ENST00000866881, ENST00000866882, ENST00000866883, ENST00000866884, ENST00000866885, ENST00000866886, ENST00000866887, ENST00000866888, ENST00000927933, ENST00000927934, ENST00000927935, ENST00000927936, ENST00000967242, ENST00000967243, ENST00000967244, ENST00000967245
RefSeq mRNA: 3 — MANE Select: NM_030913
NM_001178061, NM_001178062, NM_030913
CCDS: CCDS53363, CCDS53364, CCDS984
Canonical transcript exons
ENST00000368914 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000960008 | 151138316 | 151138406 |
| ENSE00000960009 | 151137986 | 151138105 |
| ENSE00000960010 | 151137711 | 151137799 |
| ENSE00000960011 | 151136857 | 151137074 |
| ENSE00000960012 | 151136448 | 151136579 |
| ENSE00000960013 | 151136011 | 151136163 |
| ENSE00000960014 | 151135591 | 151135764 |
| ENSE00001044830 | 151139976 | 151140090 |
| ENSE00001044836 | 151139425 | 151139481 |
| ENSE00001044838 | 151135163 | 151135309 |
| ENSE00001044850 | 151134401 | 151134445 |
| ENSE00001044852 | 151139638 | 151139701 |
| ENSE00001384481 | 151144385 | 151144434 |
| ENSE00001402481 | 151131707 | 151133517 |
| ENSE00001435855 | 151146433 | 151146631 |
| ENSE00001448277 | 151142504 | 151142675 |
| ENSE00003512606 | 151138630 | 151138731 |
| ENSE00003636166 | 151134620 | 151134675 |
| ENSE00003636361 | 151134798 | 151134875 |
Expression profiles
Bgee: expression breadth ubiquitous, 176 present calls, max score 98.02.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.7335 / max 278.6237, expressed in 1271 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14404 | 5.4034 | 1108 |
| 14406 | 1.1325 | 543 |
| 14405 | 0.1976 | 78 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 98.02 | gold quality |
| apex of heart | UBERON:0002098 | 96.81 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.49 | gold quality |
| type B pancreatic cell | CL:0000169 | 95.56 | gold quality |
| muscle of leg | UBERON:0001383 | 95.46 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 94.95 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.82 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.74 | gold quality |
| right testis | UBERON:0004534 | 94.34 | gold quality |
| olfactory bulb | UBERON:0002264 | 94.18 | gold quality |
| ganglionic eminence | UBERON:0004023 | 94.05 | gold quality |
| left testis | UBERON:0004533 | 93.91 | gold quality |
| muscle organ | UBERON:0001630 | 93.73 | gold quality |
| cortical plate | UBERON:0005343 | 93.03 | gold quality |
| cerebellum | UBERON:0002037 | 93.02 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 92.17 | gold quality |
| triceps brachii | UBERON:0001509 | 91.97 | gold quality |
| heart left ventricle | UBERON:0002084 | 91.95 | gold quality |
| cardiac ventricle | UBERON:0002082 | 91.68 | gold quality |
| sural nerve | UBERON:0015488 | 91.17 | gold quality |
| testis | UBERON:0000473 | 90.96 | gold quality |
| parotid gland | UBERON:0001831 | 90.79 | gold quality |
| right atrium auricular region | UBERON:0006631 | 90.74 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 90.15 | gold quality |
| cardiac atrium | UBERON:0002081 | 89.79 | gold quality |
| gluteal muscle | UBERON:0002000 | 89.62 | gold quality |
| vastus lateralis | UBERON:0001379 | 88.80 | gold quality |
| heart | UBERON:0000948 | 88.73 | gold quality |
| tibial nerve | UBERON:0001323 | 88.67 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 88.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.42 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
25 targeting SEMA6C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-3714 | 99.71 | 70.74 | 2671 |
| HSA-MIR-4465 | 99.71 | 72.56 | 2096 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-4284 | 99.36 | 65.25 | 1293 |
| HSA-MIR-1245B-5P | 98.88 | 66.55 | 576 |
| HSA-MIR-3142 | 98.88 | 66.09 | 529 |
| HSA-MIR-3135B | 98.61 | 65.33 | 1470 |
| HSA-MIR-6842-3P | 98.07 | 66.33 | 1325 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-3131 | 95.33 | 65.74 | 102 |
| HSA-MIR-11400 | 94.03 | 67.12 | 81 |
| HSA-MIR-611 | 93.79 | 64.24 | 81 |
| HSA-MIR-744-5P | 93.78 | 65.29 | 230 |
Literature-anchored findings (GeneRIF, showing 1)
- identification, characterization, and functional study of the two novel human members of the semaphorin gene family (PMID:12110693)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sema6cb | ENSDARG00000000189 |
| danio_rerio | sema6ca | ENSDARG00000002748 |
| mus_musculus | Sema6c | ENSMUSG00000038777 |
| rattus_norvegicus | Sema6c | ENSRNOG00000021101 |
Paralogs (19): SEMA3F (ENSG00000001617), SEMA3G (ENSG00000010319), SEMA3B (ENSG00000012171), SEMA3A (ENSG00000075213), SEMA3C (ENSG00000075223), SEMA5B (ENSG00000082684), SEMA6A (ENSG00000092421), SEMA4G (ENSG00000095539), SEMA5A (ENSG00000112902), SEMA4F (ENSG00000135622), SEMA6D (ENSG00000137872), SEMA7A (ENSG00000138623), SEMA3D (ENSG00000153993), SEMA6B (ENSG00000167680), SEMA4C (ENSG00000168758), SEMA3E (ENSG00000170381), SEMA4B (ENSG00000185033), SEMA4D (ENSG00000187764), SEMA4A (ENSG00000196189)
Protein
Protein identifiers
Semaphorin-6C — Q9H3T2 (reviewed: Q9H3T2)
Alternative names: Semaphorin-Y
All UniProt accessions (1): Q9H3T2
UniProt curated annotations — full annotation on UniProt →
Function. Shows growth cone collapsing activity on dorsal root ganglion (DRG) neurons in vitro. May be a stop signal for the DRG neurons in their target areas, and possibly also for other neurons. May also be involved in the maintenance and remodeling of neuronal connections.
Subcellular location. Cell membrane.
Tissue specificity. In adult tissues, expressed only in skeletal muscle.
Similarity. Belongs to the semaphorin family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H3T2-1 | 1, Short 1 | yes |
| Q9H3T2-2 | 2, Short 2 | |
| Q9H3T2-3 | 3, Long |
RefSeq proteins (3): NP_001171532, NP_001171533, NP_112175* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001627 | Semap_dom | Domain |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR027231 | Semaphorin | Family |
| IPR036352 | Semap_dom_sf | Homologous_superfamily |
Pfam: PF01403
UniProt features (28 total): disulfide bond 8, region of interest 5, glycosylation site 3, topological domain 2, splice variant 2, sequence conflict 2, signal peptide 1, chain 1, compositionally biased region 1, sequence variant 1, transmembrane region 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H3T2-F1 | 72.13 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (8): 111–121, 139–148, 262–373, 287–332, 479–510, 519–537, 525–570, 529–545
Glycosylation sites (3): 70, 286, 437
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 185 (showing top):
MODULE_52, GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT, GOBP_NEURON_PROJECTION_EXTENSION, GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION, GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH, GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH, MODULE_45, GOBP_GROWTH, GOCC_CELL_SURFACE, GOBP_NEUROGENESIS, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, MODULE_16, CHX10_01, GGGTGGRR_PAX4_03, GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT
GO Biological Process (8): neural crest cell migration (GO:0001755), axon guidance (GO:0007411), positive regulation of cell migration (GO:0030335), negative regulation of axon extension (GO:0030517), semaphorin-plexin signaling pathway (GO:0071526), nervous system development (GO:0007399), cell differentiation (GO:0030154), negative chemotaxis (GO:0050919)
GO Molecular Function (3): semaphorin receptor binding (GO:0030215), chemorepellent activity (GO:0045499), protein binding (GO:0005515)
GO Cellular Component (4): cytoplasm (GO:0005737), plasma membrane (GO:0005886), cell surface (GO:0009986), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| neural crest cell development | 1 |
| mesenchymal cell migration | 1 |
| axonogenesis | 1 |
| neuron projection guidance | 1 |
| cell migration | 1 |
| regulation of cell migration | 1 |
| positive regulation of cell motility | 1 |
| negative regulation of cell growth | 1 |
| regulation of axon extension | 1 |
| negative regulation of developmental growth | 1 |
| axon extension | 1 |
| negative regulation of axonogenesis | 1 |
| cell surface receptor signaling pathway | 1 |
| system development | 1 |
| cellular developmental process | 1 |
| chemotaxis | 1 |
| signaling receptor binding | 1 |
| receptor ligand activity | 1 |
| negative chemotaxis | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SEMA6C | PLXNA1 | Q9UIW2 | 918 |
| SEMA6C | PLXNA2 | O75051 | 762 |
| SEMA6C | PLXNA4 | Q9HCM2 | 723 |
| SEMA6C | PLXNA3 | P51805 | 706 |
| SEMA6C | PLXND1 | Q9Y4D7 | 682 |
| SEMA6C | PLXNC1 | O60486 | 622 |
| SEMA6C | NGF | P01138 | 492 |
| SEMA6C | PRICKLE3 | O43900 | 390 |
| SEMA6C | PRICKLE2 | Q7Z3G6 | 383 |
| SEMA6C | CELSR2 | Q9HCU4 | 379 |
| SEMA6C | EFNB1 | P98172 | 365 |
| SEMA6C | BCL11B | Q9C0K0 | 365 |
| SEMA6C | NUDT5 | Q9UKK9 | 365 |
| SEMA6C | CD19 | P15391 | 353 |
| SEMA6C | SLIT3 | O75094 | 353 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SEMA6C | HSPA5 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (5): SEMA6C (Two-hybrid), SEMA6C (Affinity Capture-RNA), HSPA5 (Affinity Capture-MS), SEMA6C (Affinity Capture-RNA), SEMA6C (Protein-peptide)
ESM2 similar proteins: A0A5F4BST2, A0PJX4, A0RZB4, A1L515, A2A9Q0, A2BDG0, A6QQ85, A6XN32, A9JSM3, B0FP48, D3YZZ2, D4A2Q0, E5RIL1, F1SAM7, P01183, Q1RMK9, Q3UPR0, Q3ZCQ3, Q5BIV7, Q5BIV9, Q5BK01, Q5GH56, Q5GH64, Q5GH72, Q5SNT2, Q5T7M4, Q6IEE6, Q6PRD1, Q6UWJ8, Q70RD5, Q864V4, Q86UD0, Q8BWU1, Q8BX43, Q8CCB5, Q8IVY1, Q8K064, Q8K2Y3, Q8K5A9, Q8N9H8
Diamond homologs: A7MB70, B3EWZ3, B3EWZ8, C0HL12, C5IAW9, D3YXG0, D3ZTD8, F1LW30, G1FC92, O08665, O08721, O08722, O08747, O09126, O14514, O15041, O35464, O42236, O42237, O54951, O60242, O70141, O88632, O95025, O95185, O95754, P11680, P27918, P35441, P58397, P70275, Q13214, Q13275, Q13591, Q14563, Q17330, Q24322, Q24323, Q26261, Q26473
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 2 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
5906 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:151137002:A:G | W277R | 1.000 |
| 1:151137002:A:T | W277R | 1.000 |
| 1:151136085:G:C | F395L | 0.999 |
| 1:151136085:G:T | F395L | 0.999 |
| 1:151136087:A:G | F395L | 0.999 |
| 1:151136483:C:A | W357C | 0.999 |
| 1:151136483:C:G | W357C | 0.999 |
| 1:151136485:A:G | W357R | 0.999 |
| 1:151136485:A:T | W357R | 0.999 |
| 1:151136985:C:A | K282N | 0.999 |
| 1:151136985:C:G | K282N | 0.999 |
| 1:151136995:G:A | S279F | 0.999 |
| 1:151137000:C:A | W277C | 0.999 |
| 1:151137000:C:G | W277C | 0.999 |
| 1:151137046:C:G | C262S | 0.999 |
| 1:151137047:A:T | C262S | 0.999 |
| 1:151137061:C:G | R257P | 0.999 |
| 1:151137790:A:C | F226C | 0.999 |
| 1:151137790:A:G | F226S | 0.999 |
| 1:151138051:A:T | V201D | 0.999 |
| 1:151138072:A:C | F194C | 0.999 |
| 1:151138094:A:C | Y187D | 0.999 |
| 1:151138351:A:C | F171C | 0.999 |
| 1:151138358:A:G | C169R | 0.999 |
| 1:151138643:C:G | C148S | 0.999 |
| 1:151138644:A:G | C148R | 0.999 |
| 1:151138644:A:T | C148S | 0.999 |
| 1:151138670:C:T | C139Y | 0.999 |
| 1:151138723:G:C | C121W | 0.999 |
| 1:151138724:C:G | C121S | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000098727 (1:151144463 G>A), RS1000135057 (1:151137940 T>C), RS1000369229 (1:151133279 C>G), RS1000400519 (1:151138198 C>A), RS1000514621 (1:151133766 T>G), RS1000654044 (1:151145257 C>G), RS1000885242 (1:151144644 G>A), RS1000906914 (1:151145584 G>A), RS1001004104 (1:151139911 T>C,G), RS1001099120 (1:151145929 G>A,C,T), RS1001180255 (1:151131786 G>A,C), RS1001209597 (1:151131532 GA>G), RS1001477370 (1:151133963 G>A,C,T), RS1001539867 (1:151139612 GC>G), RS1001780882 (1:151145679 C>G)
Disease associations
OMIM: gene MIM:609294 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002783_114 | Body mass index | 5.000000e-06 |
| GCST002783_130 | Body mass index | 2.000000e-06 |
| GCST002783_311 | Body mass index | 3.000000e-06 |
| GCST90002394_81 | Monocyte percentage of white cells | 4.000000e-14 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0007989 | monocyte percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | increases methylation | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Azacitidine | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.